Anlotinib plus Docetaxel versus Docetaxel as 2nd Line Treatment in Advanced Non-Small Cell Lung Cancer: A Phase I/II Study

被引：0
|
作者：
Fang, Y. [1 ]
Pan, H. [1 ]
Shou, J. [2 ]
Hong, W. [3 ]
Yang, X. [4 ]
Zhu, D. [5 ]
Zhou, Y. [6 ]
Lan, F. [7 ]
Rao, C. [8 ]
Chen, J. [9 ]
机构：
[1] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Med Oncol, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Hangzhou, Peoples R China
[3] Univ Chinese Acad Sci, Canc Hosp, Hangzhou, Peoples R China
[4] First Hosp Jiaxing, Jiaxing, Peoples R China
[5] Jinhua Municipal Cent Hosp, Jinhua, Zhejiang, Peoples R China
[6] Cent Hosp Lishui City, Lishui, Peoples R China
[7] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou, Peoples R China
[8] Univ Chinese Acad Sci, Hwa Mei Hosp, Ningbo, Peoples R China
[9] Ningbo Univ, Affiliated Peoples Hosp, Ningbo, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Anlotinib; NSCLC; anti-angiogenesis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P86.22
引用
收藏
页码：S682 / S682
页数：1
相关论文
共 50 条
  • [31] Front-line treatment of advanced non-small cell lung cancer with docetaxel and Gemcitabine: A multicenter phase II trial
    Georgoulias, V
    Kourousis, C
    Kakolyris, S
    Dimopoulos, MA
    Papadakis, E
    Apostolopulou, F
    Agelidou, A
    Tzianni, V
    Sarra, E
    Vardakis, N
    ANNALS OF ONCOLOGY, 1998, 9 : 94 - 94
  • [32] Docetaxel plus carboplatin versus docetaxel for the patients with old age or poor performance in advanced non-small cell lung cancer: randomized phase III study
    Kang, Byung Woog
    Lee, Dae Ho
    Suh, Cheolwon
    Lee, Jung Shin
    Choi, Chang Min
    Tae-Sun, Shim
    Kim, Woo-Sung
    Hong, Jeong Sook
    Sang-We, Kim
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S546 - S546
  • [33] Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice
    Mattson, K
    Bosquee, L
    Dabouis, G
    Le Groumellec, A
    Pujol, JL
    Marien, S
    Stupp, R
    Douillard, JY
    Brägas, B
    Berille, J
    Olivares, R
    Le Chevalier, T
    LUNG CANCER, 2000, 29 (03) : 205 - 216
  • [34] Phase II study of docetaxel in inoperable advanced non small cell lung cancer
    Robinet, G
    Thomas, P
    Pérol, M
    Vergnenegre, A
    Lena, H
    Taytard, A
    Paillotin, D
    Bessa, E
    Schuller-Lebeau, MP
    BULLETIN DU CANCER, 2000, 87 (03) : 253 - 258
  • [35] Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer:: a lung cancer Galician group phase II study
    Casal, Joaquin
    Amenedo, Margarita
    Mel, Jose Ramon
    Anton, Luis Miguel
    Rodriguez-Lopez, Ruben
    Lopez-Lopez, Rafael
    Gonzalez-Ageitos, Ana
    Castellanos, Javier
    Constenla, Manuel
    Tisaire, Jose L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (05) : 725 - 732
  • [36] Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study
    Joaquín Casal
    Margarita Amenedo
    José Ramón Mel
    Luis Miguel Antón
    Rubén Rodríguez-López
    Rafael López-López
    Ana González-Ageitos
    Javier Castellanos
    Manuel Constenla
    José L. Tisaire
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 725 - 732
  • [37] Anlotinib plus docetaxel vs. docetaxel alone for advanced non-small-cell lung cancer patients who failed first-line treatment: A multicenter, randomized phase II trial
    Pu, Xingxiang
    Xiao, Zemin
    Li, Jia
    Wu, Zhijun
    Ma, Zhongxia
    Weng, Jie
    Xiao, Maoliang
    Chen, Yanhua
    Cao, Yongqing
    Cao, Peiguo
    Wang, Qianzhi
    Xu, Yan
    Li, Kang
    Chen, Bolin
    Xu, Fang
    Liu, Liyu
    Kong, Yi
    Zhang, Hui
    Duan, Huaxin
    Wu, Lin
    LUNG CANCER, 2024, 191
  • [38] A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer
    Kunitoh, H
    Akiyama, Y
    Kusaba, H
    Yamamoto, N
    Sekine, I
    Ohe, Y
    Kubota, K
    Tamura, T
    Shinkai, T
    Kodama, T
    Goto, K
    Niho, S
    Nishiwaki, Y
    Saijo, N
    LUNG CANCER, 2001, 33 (2-3) : 259 - 265
  • [39] A phase II study of docetaxel (D) plus imatinib (I) in patients with previously treated non-small cell lung cancer
    White, L. A., Jr.
    Schmidt, A. M.
    Sjak-Shie, N. N.
    Greco, A. O.
    Cronin, B.
    Fisher, K. L.
    Eckardt, J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] Docetaxel (Taxotere) and vinorelbine in the treatment of advanced non-small cell lung cancer: Preliminary results of a phase I/II trial
    Miller, VA
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : S15 - S17
12345